Comparative metabolic effects of hydrochlorothiazide and indapamide in hypertensive diabetic patients receiving ACE inhibitor therapy

Diabetic Medicine

Volumn 20, Issue 9, 2003, Pages 708-712

  Krum, Henry ^a   Skiba, M ^a   Gilbert, R E ^b  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

ACE inhibitor; Diabetes mellitus; Diuretic; Hypertension; Indapamide; Thiazide

Indexed keywords

ALBUMIN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOSINOPRIL; HYDROCHLOROTHIAZIDE; INDAPAMIDE; POTASSIUM; ANTIHYPERTENSIVE AGENT; DIURETIC AGENT; THIAZIDE DIURETIC AGENT;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; HEART RATE; HUMAN; HYPERTENSION; MONOTHERAPY; OPEN STUDY; POTASSIUM BLOOD LEVEL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; CROSSOVER PROCEDURE; DIABETIC ANGIOPATHY; DRUG COMBINATION; FEMALE; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; SINGLE BLIND PROCEDURE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIURETICS; DRUG THERAPY, COMBINATION; FEMALE; FOSINOPRIL; HEART RATE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; INDAPAMIDE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 0642274857     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2003.01023.x     Document Type: Article

References (21)

1. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-194.
2. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, for the Collaborative Study Group. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456-1462.
3. Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359: 1004-1010.
4. Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000; 355: 253-259.
5. Black HR, Cohen JD, Kaplan NM, Ferdinand KC, Chobanian AV, Dustan HP et al. The sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413-2446.
6. Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 2000; 36: 646-661.
7. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J 1998; 317: 703-713.
8. Cremonesi G, Cavalieri L, Cikes I, Dobovisek J, Bacchelli S, Degli Esposti D et al. Fixed combinations of delapril plus indapamide vs fosinopril plus hydrochlorothiazide in mild to moderate essential hypertension. Adv Ther 2002; 19: 129-137.
9. Perez-Stable E, Caralis PV. Thiazide-induced disturbances in carbohydrate, lipid, and potassium metabolism. Am Heart J 1983; 106: 245-251.
10. Gerber A, Weidmann P, Bianchetti MG, Ferrier C, Laederach K, Mordasini R et al. Serum lipoproteins during treatment with the antihypertensive agent indapamide. Hypertension 1985; 7: II164-169.
11. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional Report of a WHO Consultation. Diabet Med 1998; 15: 539-553.
12. Guidelines Sub-committee of the World Health Organization. World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. J Hypertens 1999; 17: 151-183.
13. Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. Br Med J 2000; 321: 412-419.
14. Andren L. General considerations in selecting antihypertensive agents in patients with type II diabetes mellitus and hypertension. Am J Med 1989; 87: 39S-41S.
15. Ames RP. The influence of non-beta-blocking drugs on the lipid profile: are diuretics outclassed as initial therapy for hypertension? Am Heart J 1987; 114: 998-1006.
16. Ames RP. A comparison of blood lipid and blood pressure responses during the treatment of systemic hypertension with indapamide and with thiazides. Am J Cardiol 1996; 77: 12b-16b.
17. O'Byrne S, Feely J. Effects of drugs on glucose tolerance in non-insulin-dependent diabetics (Part I). Drugs 1990; 40: 6-18.
18. Raggi U, Palumbo P, Moro B, Bevilacqua M, Norbiato G. Indapamide in the treatment of hypertension in non-insulin-dependent diabetes. Hypertension 1985; 7: II157-60.
19. Harrower AD, McFarlane G, Donnelly T, Gray CE. Effect of indapamide on blood pressure and glucose tolerance in non-insulin-dependent diabetes. Hypertension 1985; 7: II161-3.
20. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br Med J 2000; 321: 405-112.
21. Spence JD, Huff M, Barnett PA. Effects of indapamide versus hydrochlorothiazide on plasma lipids and lipoproteins in hypertensive patients: a direct comparison. Can J Clin Pharmacol 2000; 7: 32-37.